Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
NEUROTECH INTERNATIONAL LIMITED (NTI)ASX AI Signals has generated 3 signal for NTI during the last 90 days, indicating active trading activity and ongoing AI monitoring
Latest NTI Signals | |
| 03/07/2026 | BUY |
| 15/05/2026 | SELL |
| 13/05/2026 | BUY |
NTI Share Price | |
| Current Price | $0.017 |
| 52 Week High | $0.025 |
| 52 Week Low: | $0.010 |
| Trading at (% of 52 Week High) | 68.00% |
Neurotech International Limited (ASX: NTI) is a company focused on developing and commercializing medical devices and technologies for neurological conditions. Their products aim to provide innovative treatments for brain health and neurological disorders. The company operates primarily in the healthcare and medical technology sectors.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
While the AI signal indicates a BUY, the extremely low stock price and limited market capitalization suggest high volatility and speculative risk. Additional fundamental and technical analysis is recommended before making an investment decision.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But while theLatest NEUROTECH INTERNATIONAL LIMITED(NTI) News
Is Neurotech International (ASX:NTI) In A Good Position To Deliver On Growth Plans?
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial